Interindividual and Intraindividual Responses to PCSK9 Inhibition-Reply

Affiliations

Comment

Arman Qamar et al. JAMA Cardiol. 2019.

. 2019 Jun 1;4(6):600-601.

doi: 10.1001/jamacardio.2019.1200.

¹ TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data.
Qamar A, Giugliano RP, Keech AC, Kuder JF, Murphy SA, Kurtz CE, Wasserman SM, Sever PS, Pedersen TR, Sabatine MS. Qamar A, et al. JAMA Cardiol. 2019 Jan 1;4(1):59-63. doi: 10.1001/jamacardio.2018.4178. JAMA Cardiol. 2019. PMID: 30540337 Free PMC article. Clinical Trial.
Interindividual and Intraindividual Responses to PCSK9 Inhibition.
Thompson PD. Thompson PD. JAMA Cardiol. 2019 Jun 1;4(6):600. doi: 10.1001/jamacardio.2019.1194. JAMA Cardiol. 2019. PMID: 31042263 No abstract available.